If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,060.00    -188.00 (-8.36%)
Bid:
2,074.00
Ask:
2,084.00
Spread: 10.00 (0.482%)
Market Cap: £1.37b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Director/PDMR Shareholding

10 Sep 2010 14:00

RNS Number : 4952S
Genus PLC
10 September 2010
 

10 September 2010

FOR IMMEDIATE RELEASE 

 

 

GENUS plc

('Genus' or 'the Company')

 

Directors' and PDMRs' Share Options

 

Genus announces that conditional nil-cost share options were granted under the Genus 2004 Performance Share Plan ("the Plan") today to John Worby, Group Finance Director, as to 37,680 ordinary shares of 10 pence each in the Company ("Shares"), to Ian Biggs, Head of Global Product & Business Strategy, as to 27,404 Shares, to Thomas Philip Acton, Chief Operating Officer of Europe & The Far East as to 27,404 Shares, to Bill Christianson, Chief Operating Officer of The Americas, as to 24,418 Shares, to Ian Farrelly, Group Company Secretary & General Counsel as to 21,923 Shares and to David Crosby, Group Financial Controller, as to 19,457 Shares.

 

These options are subject to performance conditions which relate to growth in the Company's earnings per share over a three year period and which trigger vesting on an incremental basis.

 

John Worby's direct shareholding stands at 10,000 Shares representing 0.017% of the issued share capital of the Company. In addition, he is the beneficial owner of 166,220 nil-cost options. 

 

Ian Biggs' direct shareholding stands at 3,375 Shares representing 0.006% of the issued share capital of the Company. In addition, he is the beneficial owner of 143,894 conditional shares and nil-cost options. 

 

Thomas Philip Acton's direct shareholding stands at 21,104 Shares representing 0.035% of the issued share capital of the Company. In addition, he is the beneficial owner of 136,589 conditional shares and nil-cost options.

 

Bill Christianson has no direct shareholding in the Company and is the beneficial owner of 36,500 nil-cost share options and 34,693 market value share options.

 

Ian Farrelly has no direct shareholding in the Company and is the beneficial owner of 92,200 conditional shares and nil-cost share options.

 

David Crosby has no direct shareholding in the Company and is the beneficial owner of 38,861 nil-cost share options and 16,373 market value share options. 

 

 

For further information please contact:

 

Cara Crichton

Company Secretarial Assistant

Genus plc

 

Tel: 01256 345996

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSURORRRWAKAAR
Date   Source Headline
25th Sep 20206:14 pmRNSDirector/PDMR Shareholding
23rd Sep 20209:35 amRNSDirector/PDMR Shareholding
16th Sep 202012:16 pmRNSDirector/PDMR Shareholding
15th Sep 20205:52 pmRNSDirector/PDMR Shareholding
9th Sep 202012:17 pmRNSNOTIFICATION OF MAJOR HOLDINGS
8th Sep 20203:16 pmRNSApplication for Additional Listing
8th Sep 20207:00 amRNSPreliminary Results
1st Sep 20201:03 pmRNSTotal Voting Rights
3rd Aug 20204:15 pmRNSBlock listing Interim Review
1st Jul 202010:41 amRNSTotal Voting Rights
30th Jun 20203:45 pmRNSNOTIFICATION OF MAJOR HOLDINGS
29th Jun 20207:00 amRNSDirectorate Appointment
14th May 20206:23 pmRNSApplication for Block Listing
1st May 20203:04 pmRNSTotal Voting Rights
30th Apr 202010:24 amRNSCompliance with LR 9.2.6ER(1)
22nd Apr 20205:47 pmRNSDirector/PDMR Shareholding
21st Apr 202012:14 pmRNSNotification of Major Holdings
20th Apr 20209:28 amRNSDirector/PDMR Shareholding
8th Apr 20207:00 amRNSDirector/PDMR Shareholding
1st Apr 20205:52 pmRNSTotal Voting Rights
27th Feb 20207:00 amRNSInterim Results
26th Feb 202012:44 pmRNSNOTIFICATION OF MAJOR HOLDINGS
17th Feb 20205:27 pmRNSNotification of Major Holdings
7th Feb 20209:03 amRNSNotification of Major Holdings
3rd Feb 202010:51 amRNSBlock listing Interim Review
23rd Jan 20203:52 pmRNSNotification of Major Holdings
2nd Jan 202010:02 amRNSTotal Voting Rights
12th Dec 20192:17 pmRNSNOTIFICATION OF MAJOR HOLDINGS
2nd Dec 20194:45 pmRNSTotal Voting Rights
20th Nov 20197:00 amRNSAppointment of Chief Financial Officer
15th Nov 20196:18 pmRNSDirector/PDMR Shareholding
14th Nov 20191:23 pmRNSResult of AGM
14th Nov 20197:00 amRNSAGM TRADING UPDATE
1st Nov 201912:05 pmRNSTotal Voting Rights
14th Oct 20198:00 amRNSAnnual Report and Annual General Meeting
10th Oct 20193:30 pmRNSDirector/PDMR Shareholding
3rd Oct 20193:06 pmRNSNOTIFICATION OF MAJOR HOLDINGS
2nd Oct 20193:38 pmRNSNotification of Major Holdings
1st Oct 20195:23 pmRNSTotal Voting Rights
20th Sep 201912:38 pmRNSDirector/PDMR Shareholding
18th Sep 20196:09 pmRNSDirector/PDMR Shareholding
17th Sep 20191:24 pmRNSDirector/PDMR Shareholding
12th Sep 20192:59 pmRNSDirector/PDMR Shareholding
11th Sep 20198:02 amRNSCORRECTION: Outcome of IntelliGen Litigation
11th Sep 20197:00 amRNSOutcome of latest IntelliGen Litigation
10th Sep 20197:00 amRNSOUTCOME IN LATEST INTELLIGEN LITIGATION
5th Sep 20197:00 amRNSPreliminary Results
22nd Aug 20197:00 amRNSAppointment of Chief Executive Officer
1st Aug 20195:49 pmRNSBlock listing Interim Review
1st Aug 20195:46 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.